NeuroSymmetry® Biotechnology Corporation (SG) Pte Ltd

The NS1 technology offers a safe, effective and affordable solution for those suffering from strokes and traumatic brain conditions.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Singapore
  • Currency SGD
  • Founded May 2020
  • Employees 10
  • Incorporation Type C-corp
  • Website neurosymmetry.io

Company Summary

The NS1 is a noninvasive device that provides condition specific, pulsed electromagnetic field patterns designed to restore normal brainwave activity in those suffering from neuronal damage. The safety of the natural, Earth strength magnetic field of the NS1 and the condition specific frequency patterns provided by the device are unique selling points;

Team

Advisors

  • Todd Richards
    Unconfirmed
    Eric D. Kramer
    Unconfirmed
    Ted Robinson
    Unconfirmed
  • Jo Beth Dow
    Unconfirmed
    Rod Yetman
    Unconfirmed
    Koh Huan Fong
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free